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Tissue culture preparations of the mouse parotid tumor agent (polyoma virus) 
have  been  shown  to  agglutinate  erythrocytes  from  a  variety  of species  (1), 
agglutination being prevented by pretreatment  of red cells with  Vibrio comm~ 
filtrates. The effect of crude receptor-destroying enzyme preparations suggested 
further  studies  to  clarify  this  apparent  similarity  to  hemagglutination  by 
members  of  the  myxovirus  group.  This  report  concerns  the  relationships  of 
red  cell  receptors  and  hemagglutination  inhibitors  for  polyoma  virus  and 
selected myxoviruses, serologic comparisons of polyoma virus with  the myxo- 
viruses and certain other hemagglutinating viruses,  and additional  information 
on the properties of polyoma virus hemagglutination. 
Materials and Methods 
Polyoma Vims.--The  3919 strain  of Stewart  et d.  (2), in  first  mouse  embryo  tissue 
culture passage in this laboratory, was used in tests for hemagglutination-inhibition by antisera 
for representative  members of the myxovirus group.  For all other studies  the LID-I strain 
(3) was used. Pools of 6th to 8th mouse embryo tissue culture passage fluids, which served 
as the source of virus,  complement-fixing antigen,  and hemagglutinin,  were prepared  in 32 
ounce prescription bottle cultures of trypsin-dispersed mouse embryo fibroblasts, grown and 
maintained  as described previously  (3). Control fluids consisted of fluid and cells from un- 
inoculated mouse embryo cultures. 
Myxo~mses.--Allantoic fluid from embryonated  hens' eggs infected with influenza types 
A/Jap/305, B/GL/55,  and B/Lee, Sendal, and mumps  (Habel strain)  viruses, and monkey 
kidney tissue culture passage of "croup associated"  (CA) (Greer strain)  virus were used for 
red cell receptor  and inhibitor  destruction  experiments. Soluble complement-fixing antigens 
consisted of chorioallantoic membrane preparations  of influenza A/Jap/305  and  B/GL/55, 
Sendal, mumps, hemadsorption  (HA) type II (C-39), and Newcastle disease (NDV) viruses; 
chick embryo extract preparation  of influenza C  (1233); and ether-treated  monkey kidney 
tissue culture fluid of CA and HA type I  (C-243). Preparation  of soluble antigens has been 
described Cook et al. (4) and the antigens used in this study were supplied through the kindness 
of Dr. Cook. 
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Mouse Encephalomydi~is Virus.--Mouse brain suspensions  of the FA and GDVII strains, 
and spinal cord suspension of the TO strain were kindly supplied by Dr. Karl Habel. 
An//sera.--Antiserum  for  polyoma  virus  was  prepared  by  intraperitoneal  inoculation 
of weanling Swiss mice with  1:10 dilution of infected tissue culture fluid, using two 0.2 ml. 
injections 2 weeks apart. The mice were bled by decapitation 10 days after the second inocu- 
lation. 
For  hemaggintination-inkibition  tests,  myxovirus  antisera  included  rooster  serum  for 
various influenza A viruses (Swine,  PR8, FM1, FLW-l-52, FW-1-50, Hawaii 303, and Jap/ 
305/57),  influenza B  viruses  (1-B-l, Lee, and Va-301-55),  and influenza C  (1233);  chicken 
and guinea pig serum for NDV; guinea pig serum for Sendal, CA, and mumps; and rabbit 
serum for HA types I  and II. Myxovirus antisera used in CF tests were prepared in guinea 
pigs, using the same virus strains employed as antigens. 
Rooster antiserum  for encephalomyocarditis  (EMC)  virus was kindly supplied  by  Dr. 
Kenneth Takemoto. 
Receptor-Deslroying Enzyme (RDE).--RDE preparations  consisted of unpurified filtrates 
of 18 hour beef-heart infusion broth cultures of Vibrio comm. The two preparations used 
titered  1:16 when tested with 8 hemagglutinating units of influenza A  (PR8)  or influenza 
B  (Lee) virus. 
Complement F/~/on  (CF)  Te~t.--The modified Bengtson technique  (5)  was employed, 
using 2 full units of complement, 2 units of polyoma antigen, and 4 units of the myxovirus 
antigens. 
Red Cdl Suspens~ns.--Whole blood of various species was collected in Alsever's solution; 
the red cells were washed in 3 changes of pH 7.2 phosphate  buffered saline and stored at 
4°C. either as packed cells or as 1.0 per cent suspension in buffered saline. Guinea pig cells 
were used as routine for hemagglutination and hemaggiutinationoinkibition tests, and for ceil 
receptor modification studies. 
Hemagglutination  and  Heraagglutination-Inhibi~on  (HI)  Te~t~.~For  hemagglutination 
tests, 0.2 ml. of 0.4 per cent guinea pig red cells was added to 0.2 ml. of virus dilution. The 
tubes were shaken and the cells allowed to settle at 4°C. Readings were made in the cold by 
the pattern method. Titers were expressed as the highest dilution producing a partial pattern 
(approximately 50 per cent agglutination). 
HI tests employed 0.2 ml. serum dilution and 0.2 ml. of virus diluted  to contain 8  to 
16 hemagglutinating units.  After incubation of the mixtures for 30 minutes at room tem- 
perature, 0.1 nil. of 1.0 per cent guinea pig red cells was added, and the tubes were incubated 
at 4°C. and read as above. Titers were expressed as the highest initial serum dilution giving a 
distinct button. 
Sera were heated as routine at 56°C.  for 30 minutes before testing. RDE treatment  of 
serum consisted of ~i~ng equal volumes of undiluted unheated serum and undiluted RDE, 
or 1 volume of 1:10 serum dilution and 1/10 volume undiluted RDE, incubating for 18 hours 
at 37°C., and heating at 56°C.  for 30 minutes. 
All dilutions were made in phosphate  buffered saline, pH  7.2. 
Treatment of Red Cells with RDE.---0.2  ml. samples of 0.4 per cent guinea pig red cells 
were treated with an equal volume of serial twofold dilutions of RDE in calcium acetate 
saline  (6).  After incubation  at  room  temperature  for  90  minutes,  the  superuatant  fluid 
was removed and replaced with 8 units of hemagglutinin contained in 0.4 ml. The erythro- 
cytes were then resuspended and allowed to sediment at 4°C. 
Preparation of Virus-Treated Red Ce//s.--Gninea pig red cells were added in a  final con- 
centration  of 0.5  per cent to undiluted  allantoic fluid preparations  of influenza A  and  B 
viruses, and to undiluted polyoma virus tissue culture fluid, and the suspensions  incubated 
in a  37°C.  water bath for  18 hours.  Since polyoma-treated  red cells usually agglutinated 
spontaneously even after thorough washing in saline,  they were washed once with a  1:800 HARTLEY  ET  AL.  83 
dilution of~polyoma mouse antiserum, containing 8 HI units, inan attempt to stabilize the 
suspensions. In certain experiments, influenza A  and B  virus-treated red cells were washed 
initially in polyoma antiserum or homologous immune serum. The cells were then washed 
3  times in phosphate buffered saline and resuspended  to a  concentration of 0.4 per cent. 
Flectrophore~is.--Measurement of electrophoretic mobility was carried out on the following 
guinea pig red ceil preparations: (a) untreated cells; (b) cells exposed to control mouse embryo 
tissue culture fluid; (c) cells exposed to polyoma virus-infected tissue culture fluid having a 
hemagglutination titer of 1:2550 per 0.2 nil.; and (d)  ceils exposed to RDE.  Polyoma virus 
and control fluid treatment consisted of m~Ying 0.25 ml. packed red cells and 7.5 ml. fluid, 
holding at 4°C. for 1 hour, followed by incubation at 37°C. for 18 hours. For RDE treatment, 
0.25 ml. packed cells was added to 7.5 ml. of RDE dilution consisting of 2 parts RDE to 1 
part calcium acetate saline, and the mixture incubated at 37°C. for 2 hours. The ceils were 
washed, thoroughly and resuspended  to  1.0 per cent in phosphate buffered  saline. Virus- 
treated and 1 aliquot of control fluid-treated cells were washed once in polyoma virus mouse 
antiserum, diluted 1 : 800. 
Electrophoresis  studies  were  carried  out  in  a  microelectrophoresis apparatus  designed 
by Dr. John W. Hornibrook and used through his courtesy; the internal measurements of 
the electrophoresis chamber were  12 x 36 x 0.6 mm. The chamber was coated with 1.0 per 
cent gelatin  in distilled water before testing each sample. The time in seconds for an erythrocyte 
to travel an arbitrary distance, as measured by an ocular  micrometer,  was  determined for 
each lot of treated cells.  Four  to 7 readings were made for each group of control cells,  and 
at least 8 determinations for virus- and RDE-treated cells. 
O~omucin Inhibitor.--The  method  of  ovomucin  preparation  was  modified  from  that 
described by Gottschalk and Lind  (7). Egg white was diluted in approximately 3 volumes 
of distilled water and the resulting precipitate washed 3 times in 0.5 per cent NaC1 and re- 
suspended in 2 volumes 10 per cent NaC1. The mixture was  held  overnight at  4°C.,  cen- 
trifuged,  and  the  sediment  dispersed  in  20  volumes  distilled water.  The precipitate was 
washed 3 times and suspended in an equal volume of distilled water; 10 per cent NaC1 was 
added to a final salt concentration of 0.5 per cent and the mixture homogenized in a Waring 
blendor for 30 minutes. The supernatant fluid obtained after centrifugation at 2000 R.P.M. 
for 10 minutes was dialyzed for 50 hours against 2 changes of 1.8 per cent NaCI,  and for 
35 hours against 3 changes of 1.0 per cent NaC1,  and stored at 4°C. 
Treatment of ovomucin with virus consisted of adding 1 volume of ovomucin to 2 volumes 
of undiluted infected allantoic fluid or tissue culture fluid, and incubating at 37°C.  for 18 
hours.  To  inactivate  the  hemagglutinin  of  the  treating  virus,  ovomucin-myxovirus and 
ovomucin-potyoma virus mixtures were heated for 30 minutes at 65  ° and 70°C.,  respectively. 
Control ovomucin preparations consisted of 1:3 dilutions of ovomucin in saline and in con- 
trol mouse embryo tissue culture fluid, incubated at 37°C. for 18 hours, and heated at 70°C. 
for 30 minutes. 
To determine residual inhibitor in virus-treated ovomucin, serial 2-fold dilutions of the 
treated ovomucin samples were prepared and 0.2 ml. of test virus diluted to give a final con- 
centration of 3 to 4 units of hemagglutinin was added to 0.2 ml. of each ovomucin dilution. 
After 2 hours at 4°C., 0.1 ml. of 1.0 per cent guinea pig red cells was added to each tube; 
the tubes were placed at 4°C. and read at intervals until complete settling occurred. Controls 
consisted of titrations of each test virus and determination of the inhibitor titer of saline- 
treated and control fluid-treated ovomueln against each test virus. 
RESULTS 
Hemagglutlnation of Various Species Erythrocytes.--Tissue  culture prepara- 
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avian species. Comparable hemagglutinin titers were obtained with erythrocytes 
from humans  (type O), guinea pigs,  mice,  rkes~  and c~omolgo~ monkeys, 
and chickens;  sheep and cat red cells were agglutinated only by low dilutions. 
Marked variation was noted in the susceptibility of red ceils obtained from 
different white rats. No agglutination of horse,  cow, grivet or patas monkey, 
chimpanzee,  pigeon, alligator,  or hamster erythrocytes was obtained. However, 
Eddy (1) has obtained high hemagglutlnin titers with hamster red cells. 
Guinea pig red cells were used as routine because of the consistently high 
heInagglutination  titers obtained and the lack of variation among individual 
animals. 
Receptor Modification by RDE.--Treatment of guinea pig red cells with R.DE 
rendered them inagglutinable by polyoma virus. Prevention of polyoma virus 
hemagglutination  occurred through  1:64 dilution of RDE in a  test in which 
simultaneous titration of the RDE prevented hemagglutination by influenza A 
(PR8) to a titer of 1:16. 
Receptor Modification by Virus.--In view of the possible s~milarity of red cell 
receptors for polyoma virus and members of the myxovirus group as indicated 
by the action of  RDE, it was of  interest  to  test for  enzymatic activity of 
polyoma virus on its cell receptors, and for reciprocal receptor destruction  by 
polyoma and myxoviruses. 
Polyoma virus hemagglutinin  readily adsorbed to  guinea pig red  cells  at 
4°C.,  and  eluted at  37°C.  with  varying  efficiency.  Supematant  fluids  from 
mixtures  of guinea  pig  red  cells  and  polyoma virus-infected  tissue  culture 
fluid, held at 4°C. for 1 hour, were reduced in hemagglutination titer to 1:10 
or less, from a starting titer of 1:2560 or greater. When the cells were resus- 
pended in tissue culture maintenance medium and held at 37°C. for 30 minutes 
to 2~,~ hours,  50 to  100 per cent of the hemagglutinin  was recovered in the 
fluid phase. However, cells thus exposed remained completely agglutinable on 
subsequent treatment  with fresh virus.  The results  of titrations  of polyoma 
virus using red cells  treated  at 37°C.  for  18 hours with polyoma virus and 
influenza virus types A and B are given in Table I. The procedure described in 
Materials and Methods was followed,  with the exception that  in test 1, the 
mixtures  of cells plus treating  virus were held at 4°C.  for  1~,~ hours before 
incubation at 37°C.  Pretreatment of red cells with influenza  A and B viruses 
markedly reduced their agglutinability by polyoma virus. Receptor destruction 
was  prevented  by pre~incubation  of  the  treating  viruses  with  homologous 
immune  serum,  indicating  that  receptor  modification  was  a  result  of viral 
enzymatic activity, and was not due to some enzyme present in the aUantoic 
fluid.  Cells  exposed to  polyoma virus  showed  no  detectable  exhaustion  of 
receptors for any of the viruses tested.  One preparation  of polyoma-treated 
cells  (test 1) appeared to be somewhat more sensitive to agglutination  than 
were control cells. 
The results of electrophoresis  experiments are given in Table II. No difference HARTLEY  ET  AL. 
TABLE  I 
Tests for Reciprocal Erytkrocyte" Receptor Destruction by Polyoma Virus and Influenza 
A and B Viruses 
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Treatment of erythrocytes 
Virus 
Hemagglutlnation fiter of standard virus 
pools against tzeated cells (reciprocal) 
Polyoma 
Influenza A 
(Jap/305/57) 
¢¢ 
"  +  A antiserum~ 
Influenza B 
(GL/55) 
"  +  A antiserum~ 
"  +  B antiserum§ 
Influenza  virus 
None 
Units of 
heraa~-  Polyoma virus 
glutinm  ~, (Jap/B (GLI  per ml.  of  Initial wash of treated cells  305) 
~n~-RBC 
mixture 
Testl  Test2  Test3  Test1  Test 
Polyoma  mouse  serum 
3200  (8 HI units)  640  320  320  >64  128 
Control  mouse  serum 
10  20 
160  (1:800) or saline 
Polyoma  mouse  serum  10 
(8 HI units) 
Influenza  A  rooster 
4O 
serum (4 HI units) 
<5  Saline 
Control  mouse  serum  <2O 
150  (1:800) or saline 
Polyoma  mouse  serum  <20 
(8 HI units) 
Influenza  B  rooster  64O 
serum (4 HI units) 
320  Saline 
<5  Saline 
NT* 
8 
20  16 
320  128 
Control  mouse  serum 
(1: 800) 
Polyoma  mouse  serum 
(8 HI units) 
<20  <8 
<20  <8 
320  64 
320  320  320  32  128 
320  32 
* No test; cells agglutinated spontaneously. 
Two  volumes  treating virus pre-incubated 37°C.  1  hour with  1  volume  influenza A 
(Jap/305/57)  rooster antiserum (RDE-treated, heated 50°C.  30 minutes), with HI titer of 
1:320 against 4 units A  (Jap/305) and <  1:40 against 4 units of B  (GL). 
§ Two  volumes  treating virus pre-incubated 37°C.  1  hour with  1  volume influenza B 
(GL/55) rooster antiserum (RDE-treated, heated 50°C. 30 minutes), with HI titer of 1:640 
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in mobility of polyoma virus-treated  red cells,  as compared to untreated  or 
control  fluid-treated  cells,  was  detected  by a  procedure  which  indicated  an 
approximate 4-fold decrease in mobility of RDE-treated cells. 
Serum Inhibitors.--In standard HI tests employing 8 to 16 units of hemag- 
glutinin, RDE-sensitive inhibitor of polyoma virus hemagglutination was found 
in low titer  (1:40)  in  occasional sera from uninoculated  mice or from those 
receiving saline or control tissue culture fluids. In  tests  in  which  mouse  sera 
were  screened at  dilutions  of  1:100  and  1:200,  RDE-sensitive  inhibitor  has 
been encountered rarely. Thus, of 478 sera from uninoculated mice of a variety 
of inbred and non-inbred strains in infection-free colonies (8), only 2 demon- 
TABLE II 
Ele~tropkoreti~ Mobility of Polyoma Virus-Treated Red Cells, as Compared to Control 
and RDE-Treated  Cdls 
Cell treatment  Initial wash of treated  cells  Electrophoretlc mobility* 
None 
Control tissue  culture  fluid 
Polyoma virus 
RDE 
Saline 
Saline 
Polyoma MS$ 
Polyoma MS 
Saline 
31.0  4-  1.2 
31.1 4- 0.5 
30.3  4- 0.7 
30.2  4- 0.8 
133.7 4-  10.0 
* Expressed as time in seconds required for a red cell to travel  an arbitrary distance 
across an ocular micrometer, 
~: Polyoma-immune mouse serum diluted 1: 800 in saline (8 HI units). 
strated RDE-sensitive inhibitor, both in titers of 1:100. Among 791 Swiss mice 
receiving control inoculations, one was found to have RDE-sensitive inhibitor, 
titering 1:200. As shown in Table III, the titer of non-specific serum inhibitor 
was inversely proportional to the test dose of hemagglutinin. In contrast, only 
a 4- to 8-fold decrease in inhibitor titer of polyoma-immune mouse serum, either 
heat- or RDE-treated, was detected with a  64-fold increase in hemagglutinin. 
RDE treatment of polyoma-immune mouse, hamster, or rabbit serum had no 
significant effect on HI titers as determined  in the  standard test. 
RDE-sensitive inhibitor was found at a  dilution  of  1:160  in  2  rabbits re- 
ceiving control tissue culture fluid inoculations.  No inhibitor was detected in 
pooled chicken, calf, or sheep serum, in tests of 1: 20 dilution of unheated serum 
against 8 to 16 units of virus. 
Because of the generally low inhibitor titers, no attempt was made to carry 
out comparative tests for reciprocal destruction of serum inhibitors by polyoma 
virus and members of the myxovirus group. HARTLEY  ]~T  AL.  87 
Ovomudn Inkibitor.--An ovomucin preparation with inhibitory activity for 
myxovirus hemagglutination was  found to  contain high  titer  inhibitor for 
polyoma virus hemagglutinin, permitting cross-tests  of inhibitor destruction. 
The results of a representative cross-test are given in Table IV; these findings 
were confirmed in several additional tests. Ovomucin inhibitor titers for poly- 
oma virus  were  markedly reduced by pretreatment of  the  ovomucin with 
influenza A virus and significant reduction was noted with influenza B and CA 
viruses. No reduction in ovomucin inhibitor titer for any of the viruses tested 
was detected after treatment of ovomucin with polyoma virus.  The test pre- 
sented in the table  appears  to be  somewhat insensitive  for detecting weak 
enzymatic activity, since no destruction of mumps or Sendai virus inhibitor by 
TABLE  III 
Effea of RDE and Dose of Heraagglutinin on HI Tiler of Control and Polyoma-Immune 
Mouse Serum 
Pooled mouse 
Control* 
Polyoma- 
immune* 
Treatment of serum 
56°C., 30 rain. 
RDE, 56°C., 30 rain. 
56°C., 30 rain. 
RDE, 56°C., 30 rain. 
Reciprocal of serum HI fiter against increasing 
hemagglutinin  doses 
1U 
160 
40 
3200 
3200 
2U 
40 
20 
1600 
1600 
4U 
<20 
<20 
1600 
1600 
8U 
<20 
<20 
1600 
1600 
5u  ;2u I 54U 
.'2O 
".2O 
800  8001 8O0 
8OO  8001 4O0 
* Mice received  2  intraperitoneal inoculations with 0.2  ml.  of  1:I0  dilution of control 
tissue culture fluid or polyoma infectious tissue culture fluid, respectively. 
the homologous viruses was obtained. However, in an additional test using the 
same reagents an 8-fold reduction in Sendal inhibitor and a 2-fold reduction, of 
borderline significance, in mumps inhibitor were detected. In this test polyoma 
virus showed no evidence of enzymatic activity. 
Serologic Teas.--No inhibition of polyoma virus hemagglutination  occurred 
in tests with antisera prepared against representative strains of types A, B, and 
C influenza viruses, or against Sendal, CA, mumps, NDV, and types I and II 
HA viruses, in tests performed with 8 hemagglutinating units of polyoma virus 
and serum dilutions representing  at least 8 HI units of homologous antibody. 
CF tests using 2 units of polyoma antigen and 8 units of antiserum for the 
various myxoviruses  were completely negative. In addition, no reaction was 
obtained with 8  units of polyoma mouse  antiserum and 4  units of soluble 
myxovirus CF antigens. 
Relation  to  Other Hemagglutinating  Viruses Found in  Rod~ts.--Since  the 
hemagglutination properties  of certain other viruses  found in rodents have 88  POLYOMA  VIRUS  INFECTION.  IV 
attributes in common  with polyoma virus it was of interest to confirm the 
distinctness of polyoma virus from these agents. 
Encephalomyocarditis (EMC) virus agglutinates sheep red cells in the cold, 
and the hemagglutinin can be eluted on warming, but with no loss in agglutin- 
ability of the cells (9). Also, it has been reported that treatment with RDE 
renders red ceils inagglutinable  (10) and prevents adsorption and multiplication 
of the virus in HeLa cell cultures (11). Rooster antiserum against EMC virus, 
having an homologous neutralization titer of 1:3125, was treated with RDE; 
TABLE IV 
Cross-Tests of Destruction of Ovomucin Inhibitor  Using Polyoma Virus and Selected 
1/1 ixoviruses 
Reciprocal of ovomucin inhibitor tit~ when tested 
Ovomudn treatment  against 3 to 4 units of: 
Virus 
Iafltuenza  A (Jap/305) 
[ufluenza  B (GL) 
CA 
iendai 
Mumps 
Polyoma 
Control  tissue  culture  fluid 
;aline 
Units of 
hemagglut- 
inin per ml. 
ovomnein 
160 
320 
160 
1280 
160 
6400 
Influenza 
B  B 
A  (GL)* (Lee)" 
30 
<15  <15 
480  240  1920 
480  240  1920 
480  240  1920 
CA 
<15 
30 
30 
15 
Sendal 
120 
120 
240 
120 
Poly- 
oma 
<15 
240 
48O 
1920 
480  1920 
480  1920 
480  1920 
480  1920 
* Test virus heated at 56°C. for 30 minutes. 
Eight units of test virus. 
this serum in a  dilution of 1:40  was negative in HI tests against 8 units of 
polyoma hemagglutinin. 
The GDVII strain of mouse encephalomyelitis virus agglutinates human red 
cells in the cold, and elutes on warming, the cells remaining agglutinable (12). 
Mouse protection tests were performed in which polyoma-immune mice were 
challenged with the TO, FA, and GDVII strains. Weanling  Swiss mice were 
immunized with high fiter polyoma virus-infected tissue culture fluid by giving 
2 intraperitoneal inoculations  of undiluted fluid 1 week apart. Twenty days 
after the second injection equal numbers of polyoma-immunized  and uninocu- 
lated control mice were challenged with each strain of virus as a  10 per cent 
brain or cord suspension;  challenge with FA and GDVII strains consisted of 
intracerebral inoculation of 0.04 ml. volumes;  TO-challenged  mice  received 
0.02 ml. intraspinally. Results are given in Table V; all positive mice succumbed 
with typical paralytic symptoms. HARTLEY  ET  AL.  89 
Lung extracts from mice or hamsters infected with pneumonia virus of mice 
(PVM) contain an agglutinin for mouse and hamster red cells (13, 14). In the 
infected lung,  the virus is firmly combined with  a  tissue  component which 
prevents hemagglutination  (15). Dissociation of hemagglutinin from inhibitor 
occurs on heating to 70°C., the property of hemagglutination being much more 
stable than infectivity; such heating is also required to release  the virus from 
agglutinated  red  ceils  (14).  Reagents were not  available for serologic  com- 
parisons of polyoma virus and PVM. However, polyoma virus hemagglutinin 
and infectivity are resistant to heating at 60°C. for 30 minutes but are destroyed 
or very much reduced after 30 minutes at 70°C.  (16);  there are also marked 
differences  in pathogenicity and in the species of erythrocytes susceptible to 
agglutination. 
TABLE V 
Mouse Protection  Test witk Polyoma-lmmune Mice and Mouse Etwephalomyd#/is  Virus 
Challenge virus*  Route of inoculation  Polyoma-immune  mice  Uninoculated  mice 
TO  Intraspinal  9/9 (6-11) ~  9/10 (6-11) 
FA  Intracerebral  8/8 (4-5)  8/8 (4-5) 
GDVII  "  6/6 (4-5)  6/6 (4) 
* Strains of mouse encephalomyelitis virus. 
Numerator  ffi number succumbing with paralysis and death; denominator ffi number 
inoculated; figures in parentheses indicate range of incubation period in days. 
DISCUSSION 
The following considerations suggest that the red cell receptors involved in 
polyoma virus hemagglutination  are very similar  to the mucoprotein red cell 
substrates of myxoviruses:-- 
1. Red cells exposed to the action of RDE or to the enzymatic activity of 
influenza viruses types A and B were inagglutinable by polyoma virus. 
2. RDE-sensitive inhibitor  active against polyoma virus hemagglutiuation 
was found in certain normal sera. 
3. An ovomucin preparation inhibited polyoma virus hemagglutination,  and 
this  inhibitor  was susceptible to destructive activity by certain members of 
the myxovirus group. 
However, no enzymatic activity for polyoma virus was demonstrated, since 
polyoma virus produced no detectable modification in red cell agglutinabllity 
or  ovomucin  inhibition  of polyoma  or  myxoviruses.  Also,  no  alteration  in 
electrophoretic mobility of polyoma-treated red cells was detected. An apparent 
inhibitor of hemagglutination,  which is sensitive to heat and RDE, has been 
detected in cell-free  saline  eluates obtained after treatment of red cells with 
polyoma virus (17).  It is possible that this inhibitor represents receptor sub- 90  POLYOMA  VIRUS  INFECTION.  IV 
stance and its presence may indicate an otherwise undetectable modification of 
the red cell surface.  Repeated treatment  of red cells with fresh virus might 
result in some detectable receptor modification. 
Although  polyoma virus and  myxoviruses apparently  attach  to  the same 
erythrocyte receptors, there is adequate evidence that polyoma virus is not a 
member of the myxovirus group. The temperature instability, ether sensitivity, 
and 80 to 150 m/~ size range  considered characteristic of the myxovirus group 
are not associated with polyoma virus.  Polyoma virus withstands  prolonged 
storage at 4°C.  and heating  at 60°C.  for 30 minutes without decrease in in- 
fectivity titer (16), is ether-resistant  (18),  and has a particle size of approxi- 
mately 40 to 60 m# diameter (19). 
RDE-removable red cell receptors have been described for two other viruses 
otherwise apparently  different biologically  from members of the myxovirus 
group, namely, EMC virus and the rat virus (RV) of Kilham (20). Studies of 
destruction of cell receptors for these viruses by influenza virus action have not 
been reported. Both are serologically distinct from polyoma virus. 
SUMMARY 
Treatment of guinea pig erythrocytes with types A and B influenza  viruses 
rendered them inagglutinable by polyoma virus; also,  the inhibitory effect of 
ovomucin on polyoma virus hemagglutination was destroyed by pretreatment 
of the ovomucin with various myxoviruses. These results indicate that polyoma 
virus  and  myxovirus erythrocyte receptor  sites  are  identical.  However, no 
destruction by polyoma virus of its own or of myxovirus receptors or inhibitors 
was detected. 
No serologic relationship was detected between polyoma virus and members 
of the myxovirus group; differences  in size and stability further indicate their 
distinctness. 
No evidence was found of biologic or serologic relationship of polyoma virus 
with encephalomyocarditis virus or mouse encephalomyelitis virus. 
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